Results 121 to 130 of about 784,391 (328)

Influence diagnostics for the proportional hazards model [PDF]

, 1990
Lisa A. Weissfeld
openalex   +1 more source

Predictive maintenance of systems subject to hard failure based on proportional hazards model

Reliability Engineering & System Safety, 2020
Jiawen Hu, Piao Chen
semanticscholar   +1 more source

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

Molecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice, Jose I. Lopez, Aitziber Ugalde‐Olano, Maite Zufiaurre, Ianire Astobiza, Natalia Martin‐Martin, Laura Bozal‐Basterra, Saioa Garcia‐Longarte, Amaia Zabala‐Letona, Sofia Rey, Aida Santos‐Martin, Miguel Unda, Ana Loizaga‐Iriarte, Mariona Graupera, Paolo Nuciforo, Arkaitz Carracedo, Isabel Mendizabal   +16 more
wiley   +1 more source

Time-to-event analysis

Perspectives in Clinical Research
Survival analysis (or time-to-event analysis) deals with data where the outcome of interest is the length of time until the occurrence of an event. This type of analysis is unique because the event may not occur in all participants (known as censoring ...
Priya Ranganathan, Vishal Deo, C. S. Pramesh   +2 more
doaj   +1 more source

The Duration of Trade Revisited: Continuous-Time vs. Discrete-Time Hazards [PDF]

The recent literature on the duration of trade has predominantly analyzed the determinants of trade flow durations using Cox proportional hazards models.
Hess, Wolfgang, Persson, Maria
core  

Retinopathy prediction in type 2 diabetes: Time-varying Cox proportional hazards and machine learning models

, 2023
Panu Looareesuwan, Suparee Boonmanunt, Sukanya Siriyotha, Thitiya Lukkunaprasit, Ratchainant Thammasudjarit, Oraluck Pattanaprateep, Hataikarn Nimitphong, Sirimon Reutrakul, John Attia, Gareth J. McKay, Ammarin Thakkinstian   +10 more
openalex   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

Molecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad, Marie Austdal, Oddmund Nordgård, Gunnar Mellgren, Satu Oltedal, Marie L. Austbø, Ylva H. Vignes, Thomas Helland, Kristin Jonsdottir, Tone H. Lende, Emilius A. M. Janssen, Bjørnar Gilje, Kjersti Tjensvoll, PBCB study group, Gunnar Mellgren, Tone Hoel Lende, Anette Heie, Kristin Viste, Anita Røyneberg Alvheim, Emiel AM Janssen, Kristin Jonsdottir, Ann Cathrine Kroksveen, Thomas Helland, Einar Gudlaugsson, Oddmund Nordgård, Satu Oltedal, Kristin Løge Aanestad, Jan Terje Kvaløy, Kirsten Lode, Kari Britt Hagen, Marie Austdal, Ylva H. Vignes, Siri Tungland Sola, Nina Egeland Amundsen, Finn Magnus Eliassen, Emeritus Ernst A Lien   +35 more
wiley   +1 more source

Group sequential design for time-to-event outcome with non-proportional hazards using the concept of relative time utilizing two different Weibull distributions

Contemporary Clinical Trials Communications
A group sequential design allows investigators to sequentially monitor efficacy and safety as part of interim testing in phase III trials. Literature is well developed in the case of continuous and binary outcomes, however, in case of trials with a time ...
Milind A. Phadnis, Nadeesha Thewarapperuma, Matthew S. Mayo   +2 more
doaj   +1 more source

Functional ANOVA modeling for proportional hazards regression [PDF]

, 2000
Jianhua Z. Huang, Charles Kooperberg, Charles J. Stone, Young K. Truong   +3 more
openalex   +1 more source